The Aporia
Chow, J. (2026, October 11). Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough. South China Morning Post. https://www.scmp.com/news/hong-kong/society/article/3370459/spirit-hong-kong-awards-biotech-firm-eyes-cervical-cancer-test-breakthrough?utm_source=rss_feed
Chow, Jimmy. “Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough.” South China Morning Post, 11 Oct. 2026, https://www.scmp.com/news/hong-kong/society/article/3370459/spirit-hong-kong-awards-biotech-firm-eyes-cervical-cancer-test-breakthrough?utm_source=rss_feed.
Chow, Jimmy. “Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough.” South China Morning Post, October 11, 2026. https://www.scmp.com/news/hong-kong/society/article/3370459/spirit-hong-kong-awards-biotech-firm-eyes-cervical-cancer-test-breakthrough?utm_source=rss_feed.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
Ricky Chiu Yin-to, founder of Phase Scientific, is developing a urine-based HPV test to make cervical cancer screening more accessible. This builds on the company's success during the pandemic with its Indicaid rapid antigen test, which received US emergency-use authorization in July 2021 and was widely used in Hong Kong and internationally.
During the peak of the pandemic, Phase Scientific grew from employing around 20 to 30 people to having a workforce of up to 400. The company produced as many as 30 million rapid tests per month during this period. Chiu plans to use the funds and technological advancements gained during the pandemic to further develop long-term research initiatives, such as the cervical cancer test.